lenalidomide genthon capsules hard 20mg
genthon bv microweg 22, 6545 cm nijmegen, netherlands - lenalidomide - hard capsule - lenalidomide 20 mg - immunosuppressants
lenalidomide genthon capsules hard 25mg
genthon bv microweg 22, 6545 cm nijmegen, netherlands - lenalidomide - hard capsule - lenalidomide 25 mg - immunosuppressants
lenalidomide bioorganics capsules hard 2.5mg
bioorganics bv microweg 22, 6545cm nijmegen, netherlands - lenalidomide - hard capsule - lenalidomide 2.5 mg - immunosuppressants
lenalidomide bioorganics capsules hard 5mg
bioorganics bv microweg 22, 6545cm nijmegen, netherlands - lenalidomide - hard capsule - lenalidomide 5 mg - immunosuppressants
lenalidomide bioorganics capsules hard 7.5mg
bioorganics bv microweg 22, 6545cm nijmegen, netherlands - lenalidomide - hard capsule - lenalidomide 7.5 mg - immunosuppressants
lenalidomide bioorganics capsules hard 10mg
bioorganics bv microweg 22, 6545cm nijmegen, netherlands - lenalidomide - hard capsule - lenalidomide 10 mg - immunosuppressants
lenalidomide bioorganics capsules hard 15mg
bioorganics bv microweg 22, 6545cm nijmegen, netherlands - lenalidomide - hard capsule - lenalidomide 15 mg - immunosuppressants
lenalidomide bioorganics capsules hard 20mg
bioorganics bv microweg 22, 6545cm nijmegen, netherlands - lenalidomide - hard capsule - lenalidomide 20 mg - immunosuppressants
lenalidomide bioorganics capsules hard 25mg
bioorganics bv microweg 22, 6545cm nijmegen, netherlands - lenalidomide - hard capsule - lenalidomide 25 mg - immunosuppressants
lenalidomide capsule
dr. reddy's laboratories inc. - lenalidomide (unii: f0p408n6v4) (lenalidomide - unii:f0p408n6v4) - lenalidomide capsules in combination with dexamethasone is indicated for the treatment of adult patients with multiple myeloma (mm). lenalidomide capsules are indicated as maintenance therapy in adult patients with mm following autologous hematopoietic stem cell transplantation (auto-hsct). lenalidomide capsules are indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (mds) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities. lenalidomide capsules are indicated for the treatment of adult patients with mantle cell lymphoma (mcl) whose disease has relapsed or progressed after two prior therapies, one of which included bortezomib. lenalidomide capsules in combination with a rituximab product, is indicated for the treatment of adult patients with previously treated follicular lymphoma (fl). lenalidomide capsules in combination with a rituximab product, is indicated for the